FierceMedicalDevices names OrthoSensor as one of its "Fierce 15" Med Tech Companies of 2015

Recognition Demonstrates OrthoSensor Commitment to Improving

Clinical Outcomes and Patient Satisfaction

Dania Beach, FL – October 14, 2015– OrthoSensor, Inc., the leader in sensor-assisted surgery, today announced that it has been named by FierceMedicalDevices as one of 2015's Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. 

OrthoSensor, Inc., develops intelligent orthopedic solutions that provide real-time intraoperative data to surgeons and hospitals with proprietary sensor-assisted technologies. Our leading product, VERASENSE™ for total knee replacement, transmits quantitative data from a patient's knee, enabling a surgeon to customize implant positioning and achieve proper soft tissue balance.

"OrthoSensor is honored to receive such a great recognition," said Ivan Delevic, President and Chief Executive Officer of OrthoSensor. "We are committed to improving clinical outcomes and patient satisfaction in total knee procedures by providing orthopedic surgeons with a data driven decision support tool."

The Fierce 15 celebrates the spirit of being "fierce" – championing innovation and creativity, even in the face of intense competition.  This is FierceMedicalDevices' fourth annual Fierce 15 selection.  A complete list of "Fierce 15" companies can be found online at www.fiercemedicaldevices.com/fierce15. 

An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, FierceMedicalDevices provides subscribers with an authoritative analysis of the day's top stories. Every year FierceMedicalDevices evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors, such as the strength of its technology, partnerships, venture backers and a competitive market position.

About OrthoSensor

OrthoSensor, Inc., develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals.  The company's intelligent orthopaedic devices utilize advanced proprietary sensor and communications technologies coupled with the company's innovative software products to enable evidence-based orthopaedic surgery and a vision of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease.

Orthosensor® and VERASENSE™ are trademarks of OrthoSensor, Inc.

About FierceMedicalDevices

FierceMedicalDevices keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends and developments in medical devices and diagnostics. More than 90,000 top industry professionals rely on FierceMedicalDevices for an insider briefing on the day's top stories. Signup is free at www.fiercemedicaldevices.com/sign-up.

###

CONTACTS:

Yvette Cuello

954-666-0282

[email protected]

 

Rebecca Friend

FierceBiotech

202-824-5050

[email protected]

Suggested Articles

Medimmune’s Ronald Herbst, Ph.D., has followed a series of other AstraZeneca and its biologics arm staffers out the door.

The takeover will give Alexion two clinical-phase medicines in development in complement alternative pathway-mediated rare diseases.

Last year, Eli Lilly spent $1.6 billion to get its hands on Armo Biosciences and its lead asset, pegilodecakin. Today, that drug flopped.